Figure 4From: Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study Observed effects (efficacy analysis set) of lesogaberan 30, 90, 120 and 240 mg compared with placebo on: (A) the proximal extent of reflux; and (B) the proportion of time with esophageal pH < 4. Data are presented as geometric means with 95% confidence intervals.Back to article page